AS3MT: Difference between revisions
Jump to navigation
Jump to search
m (Bot: HTTP→HTTPS) |
imported>Boghog (removed no longer needed PBB controls and templates; removed further reading citations not specific to this gene; removed inappropriate under linked tag (there is only one sentence of prose!)) |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | {{Infobox_gene}} | ||
'''Arsenite methyltransferase''' is an [[enzyme]] that in humans is encoded by the ''AS3MT'' [[gene]].<ref name="pmid11790780">{{cite journal | vauthors = Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, Hall LL, Simeonsson JB, Thomas DJ | title = A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol | journal = | '''Arsenite methyltransferase''' is an [[enzyme]] that in humans is encoded by the ''AS3MT'' [[gene]].<ref name="pmid11790780">{{cite journal | vauthors = Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, Hall LL, Simeonsson JB, Thomas DJ | title = A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol | journal = The Journal of Biological Chemistry | volume = 277 | issue = 13 | pages = 10795–803 | date = March 2002 | pmid = 11790780 | pmc = | doi = 10.1074/jbc.M110246200 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: AS3MT arsenic (+3 oxidation state) methyltransferase| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=57412| access-date = }}</ref> | ||
== References == | == References == | ||
Line 7: | Line 7: | ||
== Further reading == | == Further reading == | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
* {{cite journal | vauthors = Dheeman DS, Packianathan C, Pillai JK, Rosen BP | title = Pathway of human AS3MT arsenic methylation | journal = Chemical Research in Toxicology | volume = 27 | issue = 11 | pages = 1979–89 | | * {{cite journal | vauthors = Dheeman DS, Packianathan C, Pillai JK, Rosen BP | title = Pathway of human AS3MT arsenic methylation | journal = Chemical Research in Toxicology | volume = 27 | issue = 11 | pages = 1979–89 | date = November 2014 | pmid = 25325836 | pmc = 4237493 | doi = 10.1021/tx500313k }} | ||
* {{cite journal | vauthors = Hernández A, Xamena N, Sekaran C, Tokunaga H, Sampayo-Reyes A, Quinteros D, Creus A, Marcos R | title = High arsenic metabolic efficiency in AS3MT287Thr allele carriers | journal = | * {{cite journal | vauthors = Hernández A, Xamena N, Sekaran C, Tokunaga H, Sampayo-Reyes A, Quinteros D, Creus A, Marcos R | title = High arsenic metabolic efficiency in AS3MT287Thr allele carriers | journal = Pharmacogenetics and Genomics | volume = 18 | issue = 4 | pages = 349–55 | date = April 2008 | pmid = 18334919 | doi = 10.1097/FPC.0b013e3282f7f46b }} | ||
* {{cite journal | vauthors = Fujihara J, Kunito T, Agusa T, Yasuda T, Iida R, Fujii Y, Takeshita H | title = Population differences in the human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene polymorphism detected by using genotyping method | journal = | * {{cite journal | vauthors = Fujihara J, Kunito T, Agusa T, Yasuda T, Iida R, Fujii Y, Takeshita H | title = Population differences in the human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene polymorphism detected by using genotyping method | journal = Toxicology and Applied Pharmacology | volume = 225 | issue = 3 | pages = 251–4 | date = December 2007 | pmid = 17889916 | doi = 10.1016/j.taap.2007.08.010 }} | ||
* {{cite journal | vauthors = Hernández A, Xamena N, Surrallés J, Sekaran C, Tokunaga H, Quinteros D, Creus A, Marcos R | title = Role of the Met(287)Thr polymorphism in the AS3MT gene on the metabolic arsenic profile | journal = | * {{cite journal | vauthors = Hernández A, Xamena N, Surrallés J, Sekaran C, Tokunaga H, Quinteros D, Creus A, Marcos R | title = Role of the Met(287)Thr polymorphism in the AS3MT gene on the metabolic arsenic profile | journal = Mutation Research | volume = 637 | issue = 1-2 | pages = 80–92 | date = January 2008 | pmid = 17850829 | doi = 10.1016/j.mrfmmm.2007.07.004 }} | ||
* {{cite journal | vauthors = Lindberg AL, Kumar R, Goessler W, Thirumaran R, Gurzau E, Koppova K, Rudnai P, Leonardi G, Fletcher T, Vahter M | title = Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms | journal = | * {{cite journal | vauthors = Lindberg AL, Kumar R, Goessler W, Thirumaran R, Gurzau E, Koppova K, Rudnai P, Leonardi G, Fletcher T, Vahter M | title = Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms | journal = Environmental Health Perspectives | volume = 115 | issue = 7 | pages = 1081–6 | date = July 2007 | pmid = 17637926 | pmc = 1913583 | doi = 10.1289/ehp.10026 }} | ||
* {{cite journal | vauthors = Schläwicke Engström K, Broberg K, Concha G, Nermell B, Warholm M, Vahter M | title = Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina | journal = | * {{cite journal | vauthors = Schläwicke Engström K, Broberg K, Concha G, Nermell B, Warholm M, Vahter M | title = Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina | journal = Environmental Health Perspectives | volume = 115 | issue = 4 | pages = 599–605 | date = April 2007 | pmid = 17450230 | pmc = 1852682 | doi = 10.1289/ehp.9734 }} | ||
* {{cite journal | vauthors = Meza M, Gandolfi AJ, Klimecki WT | title = Developmental and genetic modulation of arsenic biotransformation: a gene by environment interaction? | journal = | * {{cite journal | vauthors = Meza M, Gandolfi AJ, Klimecki WT | title = Developmental and genetic modulation of arsenic biotransformation: a gene by environment interaction? | journal = Toxicology and Applied Pharmacology | volume = 222 | issue = 3 | pages = 381–7 | date = August 2007 | pmid = 17306849 | pmc = 2040165 | doi = 10.1016/j.taap.2006.12.018 }} | ||
* {{cite journal | vauthors = Wood TC, Salavagionne OE, Mukherjee B, Wang L, Klumpp AF, Thomae BA, Eckloff BW, Schaid DJ, Wieben ED, Weinshilboum RM | title = Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies | journal = | * {{cite journal | vauthors = Wood TC, Salavagionne OE, Mukherjee B, Wang L, Klumpp AF, Thomae BA, Eckloff BW, Schaid DJ, Wieben ED, Weinshilboum RM | title = Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies | journal = The Journal of Biological Chemistry | volume = 281 | issue = 11 | pages = 7364–73 | date = March 2006 | pmid = 16407288 | doi = 10.1074/jbc.M512227200 }} | ||
* {{cite journal | vauthors = Meza MM, Yu L, Rodriguez YY, Guild M, Thompson D, Gandolfi AJ, Klimecki WT | title = Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children | journal = | * {{cite journal | vauthors = Meza MM, Yu L, Rodriguez YY, Guild M, Thompson D, Gandolfi AJ, Klimecki WT | title = Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children | journal = Environmental Health Perspectives | volume = 113 | issue = 6 | pages = 775–81 | date = June 2005 | pmid = 15929903 | pmc = 1257606 | doi = 10.1289/ehp.7780 }} | ||
* {{cite journal | vauthors = Li J, Waters SB, Drobna Z, Devesa V, Styblo M, Thomas DJ | title = Arsenic (+3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype | journal = | * {{cite journal | vauthors = Li J, Waters SB, Drobna Z, Devesa V, Styblo M, Thomas DJ | title = Arsenic (+3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype | journal = Toxicology and Applied Pharmacology | volume = 204 | issue = 2 | pages = 164–9 | date = April 2005 | pmid = 15808521 | doi = 10.1016/j.taap.2004.12.002 }} | ||
* {{cite journal | vauthors = Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S | title = Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library | journal = Gene | volume = 200 | issue = 1-2 | pages = 149–56 | | * {{cite journal | vauthors = Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S | title = Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library | journal = Gene | volume = 200 | issue = 1-2 | pages = 149–56 | date = October 1997 | pmid = 9373149 | doi = 10.1016/S0378-1119(97)00411-3 }} | ||
* {{cite journal | vauthors = Maruyama K, Sugano S | title = Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides | journal = Gene | volume = 138 | issue = 1-2 | pages = 171–4 | | * {{cite journal | vauthors = Maruyama K, Sugano S | title = Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides | journal = Gene | volume = 138 | issue = 1-2 | pages = 171–4 | date = January 1994 | pmid = 8125298 | doi = 10.1016/0378-1119(94)90802-8 }} | ||
{{refend}} | {{refend}} | ||
==External links== | == External links == | ||
* {{UCSC gene info|AS3MT}} | * {{UCSC gene info|AS3MT}} | ||
Line 27: | Line 27: | ||
{{Enzymes}} | {{Enzymes}} | ||
{{Portal bar|Molecular and Cellular Biology|border=no}} | {{Portal bar|Molecular and Cellular Biology|border=no}} | ||
[[Category:EC 2.1.1]] | |||
{{protein-stub}} | {{protein-stub}} | ||
Latest revision as of 07:23, 5 December 2018
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Arsenite methyltransferase is an enzyme that in humans is encoded by the AS3MT gene.[1][2]
References
- ↑ Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, Hall LL, Simeonsson JB, Thomas DJ (March 2002). "A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol". The Journal of Biological Chemistry. 277 (13): 10795–803. doi:10.1074/jbc.M110246200. PMID 11790780.
- ↑ "Entrez Gene: AS3MT arsenic (+3 oxidation state) methyltransferase".
Further reading
- Dheeman DS, Packianathan C, Pillai JK, Rosen BP (November 2014). "Pathway of human AS3MT arsenic methylation". Chemical Research in Toxicology. 27 (11): 1979–89. doi:10.1021/tx500313k. PMC 4237493. PMID 25325836.
- Hernández A, Xamena N, Sekaran C, Tokunaga H, Sampayo-Reyes A, Quinteros D, Creus A, Marcos R (April 2008). "High arsenic metabolic efficiency in AS3MT287Thr allele carriers". Pharmacogenetics and Genomics. 18 (4): 349–55. doi:10.1097/FPC.0b013e3282f7f46b. PMID 18334919.
- Fujihara J, Kunito T, Agusa T, Yasuda T, Iida R, Fujii Y, Takeshita H (December 2007). "Population differences in the human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene polymorphism detected by using genotyping method". Toxicology and Applied Pharmacology. 225 (3): 251–4. doi:10.1016/j.taap.2007.08.010. PMID 17889916.
- Hernández A, Xamena N, Surrallés J, Sekaran C, Tokunaga H, Quinteros D, Creus A, Marcos R (January 2008). "Role of the Met(287)Thr polymorphism in the AS3MT gene on the metabolic arsenic profile". Mutation Research. 637 (1–2): 80–92. doi:10.1016/j.mrfmmm.2007.07.004. PMID 17850829.
- Lindberg AL, Kumar R, Goessler W, Thirumaran R, Gurzau E, Koppova K, Rudnai P, Leonardi G, Fletcher T, Vahter M (July 2007). "Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms". Environmental Health Perspectives. 115 (7): 1081–6. doi:10.1289/ehp.10026. PMC 1913583. PMID 17637926.
- Schläwicke Engström K, Broberg K, Concha G, Nermell B, Warholm M, Vahter M (April 2007). "Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina". Environmental Health Perspectives. 115 (4): 599–605. doi:10.1289/ehp.9734. PMC 1852682. PMID 17450230.
- Meza M, Gandolfi AJ, Klimecki WT (August 2007). "Developmental and genetic modulation of arsenic biotransformation: a gene by environment interaction?". Toxicology and Applied Pharmacology. 222 (3): 381–7. doi:10.1016/j.taap.2006.12.018. PMC 2040165. PMID 17306849.
- Wood TC, Salavagionne OE, Mukherjee B, Wang L, Klumpp AF, Thomae BA, Eckloff BW, Schaid DJ, Wieben ED, Weinshilboum RM (March 2006). "Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies". The Journal of Biological Chemistry. 281 (11): 7364–73. doi:10.1074/jbc.M512227200. PMID 16407288.
- Meza MM, Yu L, Rodriguez YY, Guild M, Thompson D, Gandolfi AJ, Klimecki WT (June 2005). "Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children". Environmental Health Perspectives. 113 (6): 775–81. doi:10.1289/ehp.7780. PMC 1257606. PMID 15929903.
- Li J, Waters SB, Drobna Z, Devesa V, Styblo M, Thomas DJ (April 2005). "Arsenic (+3 oxidation state) methyltransferase and the inorganic arsenic methylation phenotype". Toxicology and Applied Pharmacology. 204 (2): 164–9. doi:10.1016/j.taap.2004.12.002. PMID 15808521.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (October 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Maruyama K, Sugano S (January 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
External links
- Human AS3MT genome location and AS3MT gene details page in the UCSC Genome Browser.
This protein-related article is a stub. You can help Wikipedia by expanding it. |